Aaron Wealth Advisors LLC lessened its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 31.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,822 shares of the pharmacy operator’s stock after selling 3,994 shares during the period. Aaron Wealth Advisors LLC’s holdings in CVS Health were worth $396,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health during the 3rd quarter worth $25,000. Ridgewood Investments LLC raised its stake in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the period. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health in the third quarter worth about $31,000. Legacy Investment Solutions LLC bought a new position in CVS Health in the 3rd quarter valued at $31,000. Finally, Reston Wealth Management LLC bought a new position in shares of CVS Health in the third quarter worth $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Price Performance
CVS Health stock opened at $52.72 on Tuesday. The company has a market cap of $66.35 billion, a price-to-earnings ratio of 13.38, a PEG ratio of 0.72 and a beta of 0.59. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm’s fifty day moving average is $51.34 and its 200 day moving average is $56.32.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 5.05%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.
Analyst Ratings Changes
CVS has been the topic of several research reports. Truist Financial lowered their price objective on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Evercore ISI raised their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. UBS Group boosted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. Finally, StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $68.71.
View Our Latest Stock Analysis on CVS Health
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
- Five stocks we like better than CVS Health
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What is a Dividend King?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What is the Australian Securities Exchange (ASX)
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.